Veterinary Cardiology Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Indication, End Use, Product, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Cardiology Market size was worth USD 3.3 billion in 2026 and is poised to grow at a 8.84% CAGR between 2027 and 2036, attaining USD 7.7 billion by 2036. The industry revenue for 2027 is assessed at USD 3.55 billion.
Get more details on this report
Request Free Sample ReportVeterinary Cardiology Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.79% share in 2026, supported by advanced companion animal care, specialized veterinary services, referral-based care, and higher spending on pet health.
- Asia Pacific is projected to grow at a 9.49% CAGR as veterinary care access expands, specialty services improve, and pet owners increasingly seek advanced cardiac diagnosis and treatment.
Segment Momentum
- Companion animals lead with 65.26% share due to higher screening rates, routine follow-ups, and stronger owner willingness to pursue specialized cardiac diagnostics and long-term treatment in dogs and cats.
- Production animals are expanding fastest as livestock operators increasingly link cardiovascular health with productivity and breeding value, increasing demand for diagnostic evaluation from a relatively underpenetrated base.
Market Expansion Drivers
- Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics.
- Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions.
- Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption.
Leading Market Participants
- Prominent companies in the veterinary cardiology market include Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Esaote S.p.A. (Italy), Sound Technologies Inc. (United States), Vmed Technology (United States), Zoetis Inc. (United States), Merck & Co., Inc. [Merck Animal Health] (United States), FUJIFILM Holdings Corporation (Japan).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.3 billion
- 2027 Estimated Market Size: USD 3.55 billion.
- Projected Market Size: USD 7.7 billion by 2036
- Growth Forecast: 8.84% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Companion Animals (Animal Type) | Congestive Heart Failure (Indication) | Veterinary Hospitals & Clinics (End Use) | Pharmaceuticals (Product) | Hospital/Clinic Pharmacy (Distribution Channel)
- Emerging Opportunity Segment: Production Animals (Animal Type) | Arrhythmias (Indication) | Veterinary Hospitals & Clinics (End Use) | Diagnostics (Product) | E-Commerce (Distribution Channel)
Market Growth Drivers and Industry Trends
Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics
The veterinary cardiology market is gaining momentum from the increasing recognition of cardiac diseases in dogs, particularly conditions requiring specialized evaluation and ongoing monitoring. Veterinary practices are placing greater emphasis on identifying abnormalities such as heart murmurs, rhythm disorders, and structural heart conditions through advanced diagnostic assessment. Cardiac imaging, electrocardiography, and other specialized diagnostic approaches allow veterinarians to evaluate disease progression and make more informed treatment decisions. Greater attention to canine cardiovascular health is also encouraging referrals to veterinary specialists when routine examinations reveal potential cardiac concerns, increasing the need for specialized diagnostic capabilities.
Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions
Higher spending on companion-animal healthcare is supporting the veterinary cardiology market by enabling pet owners to pursue more specialized diagnostic, therapeutic, and monitoring services for cardiac conditions. As pets increasingly receive comprehensive medical care, owners are more willing to seek veterinary intervention for chronic diseases that require continued management rather than relying only on basic clinical treatment. Cardiac therapeutics, diagnostic follow-up, and monitoring solutions can help veterinarians assess treatment response and manage disease over extended periods. The availability of increasingly specialized veterinary services is further supporting the integration of cardiac care into broader pet healthcare programs.
Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption
Veterinary education and awareness initiatives are strengthening the veterinary cardiology market by improving recognition of cardiovascular warning signs among veterinarians and pet owners. Awareness programs can encourage routine examinations, timely referrals, and greater attention to symptoms that may otherwise remain undetected until cardiac disease becomes more advanced. Early identification allows veterinary professionals to investigate suspected conditions through appropriate diagnostic procedures and establish monitoring or treatment plans when necessary. Increased dissemination of information about breed-related risks, age-associated cardiac conditions, and preventive veterinary care is also encouraging owners to discuss cardiovascular screening during regular animal health visits.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics | 2.00% | Moderate | North America, Asia Pacific, Europe | High | Near Term |
| Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions | 1.70% | Moderate | North America, Europe | High | Mid Term |
| Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption | 1.40% | Moderate | Asia Pacific, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for a 40.79% share of the veterinary cardiology market in 2026, reflecting the region's established veterinary healthcare infrastructure and strong demand for advanced companion-animal care. Increasing pet ownership and greater willingness to pursue specialized veterinary treatment are supporting demand for cardiovascular diagnosis and management. The availability of sophisticated veterinary facilities, greater awareness of animal health, and continued development of specialized clinical services further reinforce the region's leading position in veterinary cardiology.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the veterinary cardiology market, supported by improving veterinary healthcare access, increasing pet ownership, and rising awareness of specialized animal medical services. As companion animals become an increasingly important part of household life, demand is expanding beyond basic veterinary care toward more advanced diagnostic and therapeutic services. Improvements in veterinary infrastructure and growing adoption of modern clinical technologies are also creating opportunities for broader use of cardiology services across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialty Diagnostic ServicesGermany strengthens the veterinary cardiology market through widespread use of advanced diagnostic imaging and referral-based specialty services. Veterinary professionals in Germany increasingly emphasize early detection and structured management of cardiac conditions in companion animals.
France 🇫🇷
Referral Care DevelopmentFrance focuses on strengthening veterinary cardiology through referral networks and specialized clinical expertise for complex cardiovascular cases. Veterinary practices in France continue adopting advanced diagnostic tools that support accurate assessment and ongoing treatment planning.
Italy 🇮🇹
Specialized Veterinary PracticeItaly advances the veterinary cardiology market by expanding access to specialized cardiac care within companion animal practices. Italian veterinary professionals increasingly utilize echocardiography and other diagnostic technologies to support timely cardiovascular disease management.
Japan 🇯🇵
Preventive Cardiac ManagementJapan prioritizes preventive veterinary cardiology supported by routine health assessments and growing awareness of age-related heart disease in pets. Veterinary clinics in Japan continue incorporating specialized cardiac diagnostics into comprehensive animal healthcare services.
South Korea 🇰🇷
Advanced Companion HealthcareSouth Korea expands veterinary cardiology capabilities through investment in specialized pet healthcare services and modern diagnostic equipment. Veterinary providers in South Korea increasingly offer comprehensive cardiac evaluations as companion animal ownership continues evolving.
United States 🇺🇸
Companion Care ExpansionThe U.S. veterinary cardiology market is supported by increasing demand for advanced cardiac diagnostics and specialist care for companion animals. Veterinary hospitals across the U.S. continue expanding access to imaging technologies and long-term cardiovascular disease management.
Segment Leadership and Growth Trends
Veterinary Cardiology Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Companion Animals (Largest Segment) vs Production Animals (Fastest-Growing Segment)
The veterinary cardiology market was led by the companion animals segment, which accounted for a 65.26% share in 2026, supported by rising pet ownership, greater awareness of animal health, and increasing willingness among owners to pursue specialized cardiac diagnosis and treatment. Companion animals such as dogs and cats are increasingly receiving advanced veterinary care as pets are viewed as family members, encouraging demand for cardiac imaging, monitoring, and therapeutic interventions. The growing availability of specialized veterinary clinics and improved access to cardiology services further reinforces the segment's established position.
Production animals represent the fastest-growing segment, driven by increasing attention to livestock health, productivity, and disease prevention. Early identification and management of cardiovascular conditions can support animal welfare while helping producers minimize productivity losses associated with undiagnosed illness. Greater adoption of veterinary diagnostics, improving herd health management practices, and growing emphasis on preventive animal healthcare are supporting broader use of cardiology services in production settings.
Indication Segment Analysis: Congestive Heart Failure (Largest Segment) vs Arrhythmias (Fastest-Growing Segment)
Holding the largest share of the veterinary cardiology market, the congestive heart failure segment represented 40.21% in 2026, reflecting the substantial clinical need for diagnosis and long-term management of cardiac dysfunction in companion and other animals. Congestive heart failure often requires ongoing monitoring and treatment, creating sustained demand for veterinary cardiology consultations, diagnostic imaging, and therapeutic management. Increasing recognition of cardiac symptoms and improvements in veterinary diagnostic capabilities are also enabling earlier identification and more structured management of affected animals.
The arrhythmias segment is expanding rapidly as veterinary professionals increasingly use advanced diagnostic approaches to identify irregular cardiac rhythms that may otherwise remain undetected. Greater availability of electrocardiography, cardiac monitoring, and specialized veterinary expertise is improving the recognition of rhythm disorders. In addition, growing awareness of the relationship between timely cardiac assessment and animal health outcomes is encouraging more comprehensive screening and follow-up for suspected cardiovascular abnormalities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Companion Animals, Production Animals | Companion Animals | Production Animals |
| Indication | Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Others | Congestive Heart Failure | Arrhythmias |
| End Use | Veterinary Hospitals & Clinics, Others | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
| Product | Pharmaceuticals, Diagnostics | Pharmaceuticals | Diagnostics |
| Distribution Channel | Hospital/Clinic Pharmacy, Retail, E-Commerce | Hospital/Clinic Pharmacy | E-Commerce |
Competitive Landscape and Market Positioning
Prominent players in the veterinary cardiology market:
1. Boehringer Ingelheim International GmbH (Germany)
2. Ceva Santé Animale (France)
3. IDEXX Laboratories Inc. (United States)
4. Esaote S.p.A. (Italy)
5. Sound Technologies Inc. (United States)
6. Vmed Technology (United States)
7. Zoetis Inc. (United States)
8. Merck & Co. Inc. [Merck Animal Health] (United States)
9. FUJIFILM Holdings Corporation (Japan)
The veterinary cardiology market is evolving through the adoption of advanced diagnostic imaging systems and enhanced monitoring technologies designed to improve cardiac care in animals. Industry participants are increasingly introducing sophisticated solutions that support early disease detection and treatment planning, while innovation in portable and minimally invasive devices is expanding accessibility for veterinary practitioners. Rising pet healthcare expenditure is also reinforcing demand for specialized cardiology services and equipment.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Ceva Santé Animale (France) | |||||||
| IDEXX Laboratories Inc. (United States) | |||||||
| Esaote S.p.A. (Italy) | |||||||
| Sound Technologies Inc. (United States) | |||||||
| Vmed Technology (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Merck & Co. Inc. [Merck Animal Health] (United States) | |||||||
| FUJIFILM Holdings Corporation (Japan). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boehringer Ingelheim & Eko Health | Apr-26 | Boehringer Ingelheim and Eko Health launched Eko Vet+ featuring CANINEBEAT AI, an integrated diagnostic solution for the detection and grading of canine heart murmurs. By combining digital stethoscope technology with AI-driven analysis, the platform enhances diagnostic accuracy and early detection of structural heart disease in clinical veterinary settings. |
| Fujifilm | Mar-25 | Fujifilm integrated AI-automated echocardiography analysis into its LISENDO 880 ultrasound system through a partnership with Us2.ai. This technology automates complex cardiac measurements, reducing inter-observer variability and increasing diagnostic efficiency for veterinary cardiologists, thereby streamlining the assessment of cardiac structure and function in animal patients. |
| Boehringer Ingelheim | Nov-24 | Boehringer Ingelheim launched the VETMEDIN oral solution, the first FDA-approved liquid formulation for managing congestive heart failure in dogs. This innovation provides a precise, convenient alternative to traditional tablet dosing, improving compliance and therapeutic outcomes for canine patients with myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). |
| Cronus Pharma Specialties | Apr-24 | Cronus Pharma Specialties received FDA approval for the first generic Pimomedin (pimobendan) chewable tablets. This launch increases the availability of cost-effective, clinically equivalent treatment options for canine congestive heart failure, supporting broader access to standard-of-care pharmacotherapy within the veterinary cardiology market. |
| Chulalongkorn University | Jan-24 | A veterinary surgical team at Chulalongkorn University performed Thailand's first minimally invasive mitral valve repair (MVR) on a dog using a mitral clamp. This procedure eliminates the need for cardiopulmonary bypass (artificial heart/lung machine), significantly reducing surgical trauma and recovery time, and demonstrating the advancement of interventional cardiology techniques in small animal practice. |
| Invoxia | Jan-23 | Invoxia launched a smart dog collar equipped with integrated AI and biometric sensors designed to track respiratory and cardiac vitals. Developed in collaboration with veterinary specialists, the device provides continuous health monitoring and early anomaly detection, enabling proactive intervention and longitudinal data tracking for improved preventive cardiac care in domestic canine populations. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Cardiology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Mild, Moderate, Severe |
| Practice Size | Small Practices, Mid-Sized Practices, Large & Specialty Practices |
| Ownership Type | Independent Practices, Corporate Veterinary Groups, Academic & Institutional Practices |
Veterinary Cardiology Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Companion Animal Cardiac Care Referral Network Assessment |
|
| Veterinary Specialty Hospital Expansion Opportunities |
|
| Pet Insurance Coverage Impact Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of veterinary cardiology?
What are the growth projections for the veterinary cardiology industry?
How is rising incidence of canine cardiac conditions influencing diagnostic adoption in the veterinary cardiology market?
How are awareness initiatives shaping diagnostic timing and care pathways in veterinary cardiology?
Why do companion animals dominate the veterinary cardiology market?
What is driving faster growth in production animals?
Why does North America lead the veterinary cardiology market?
How is Asia Pacific driving growth in the veterinary cardiology market?
Which companies dominate the veterinary cardiology landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization